Skip to main content
Clinical Trials/NL-OMON24710
NL-OMON24710RecruitingNot Applicable

Minimal invasive follow up after flow diversion: comparison of subtraction computed tomography angiography, contrast enhanced magnetic resonance angiography and digital subtraction angiography as follow-up imaging modalities in flow diverter treatment for intracranial aneurysms

Radboudumc0 sites40 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Sponsor
Radboudumc
Enrollment
40

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Inclusion Criteria

  • In order to be eligible to participate in this study, a subject must meet all of the inclusion criteria as stated below:
  • -Aneurysm treated with a FD;
  • -=18 years;
  • -patients willing to provide written informed consent and comply with follow up requirements.

Exclusion Criteria

  • A potential subject who meets any of the following criteria will be excluded from participation in this study:
  • -Known allergy (hypersensitivity or history of major immediate or delayed skin reaction to injection) or contraindication to the contrast agent Iomeron (manifest thyrotoxicosis, recent treatment with intravenous interleukin 2) or Dotarem;
  • -Use of nephrotoxic medicines (aminoglycosides, organoplatimun compounds, high doses of methotrexate, pentamidine, foscarnet, acyclovir, ganciclovir, valaciclovir, adefovir, cidofovir, tenofovir, vancomycin, amphotericin B, immunosuppressants such as cyclosporine or tacrolimus, isosfamide);
  • -Renal insufficiency (MDRD < 60 mL/min/1,73 m2);
  • -Patient who is currently participating in another clinical research study which might be influenced by the additional imaging investigations;
  • -Patients with a contraindication for MRA (e.g. metallic implants such as a pacemaker) or a metal clip in proximity to the studied aneurysm will only receive sCTA and DSA;
  • -Female of child-bearing potential who are known to be pregnant.

Investigators

Sponsor
Radboudumc

Similar Trials

Minimal invasive follow up after flow... | Clinical Trial